Affiliate Faculty, Interim Chair and Professor, Department of Pharmaceutical Sciences and Administration (UNE)
Dr. Srinidi Mohan developed a patented test for breast cancer. In 2021, he received his second patent for a blood test identifying ovarian cancer. This blood test could be life-saving for the early detection of a cancer that is often delayed in diagnosis.
Mohan’s first patent was titled “Methods and Diagnostics for Cancer Detection and Treatment Monitoring.” His research found that the presence of blood marker Nw-hydroxy-L-Arginine (NOHA) is an identifier of certain aggressive forms of breast cancer–estrogen receptor (ER)-negative tumors. Prior to his findings, no blood marker had been found sensitive and reliable enough to identify these tumors.